Enzon Pharmaceuticals Inc. will implement a 1 for 100 reverse stock split of its common stock prior to the effective time of its planned merger with Viskase Companies, Inc.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enzon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-102127), on October 24, 2025, and is solely responsible for the information contained therein.